Literature DB >> 16405076

In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats.

Motoki Inaji1, Takahito Yoshizaki, Takashi Okauchi, Jun Maeda, Yuji Nagai, Tadashi Nariai, Kikuo Ohno, Kiyoshi Ando, Hideyuki Okano, Shigeru Obayashi, Tetsuya Suhara.   

Abstract

Positron emission tomography (PET) is a useful tool to assess and visualize neurotransmissions in vivo. In this study, we performed repeated PET scans with [11C]PE2I, a tracer of the dopamine transporter, to evaluate the alteration of the expression of dopamine (DA) transmission component after a fetal mesencephalic transplantation. The fetal mesencephalic cells were transplanted into the striatum of unilateral 6-OHDA-lesioned rats. PET scans with [11C]PE2I were performed to evaluate the DA transporter before and 2 and 4 weeks after the transplantation. Rotation behavior tests, in vitro autoradiography, measurements of DA contents in the striatum by high-performance liquid chromatography (HPLC), and tyrosine hydroxylase (TH) immunohistological examinations were performed at the same time points and examined for their relationship to changes in the dopamine transporter. The number of ipsilateral rotations induced by methamphetamine injections decreased. DA contents in the striatum measured with HPLC significantly increased. In the PET study, the binding potential of [11C]PE2I increased at 4 weeks. The results of the in vitro autoradiography study corresponded with those of the PET study. The degrees of the change in the binding potentials correlated with those of the numbers of rotations in the behavioral study and the DA contents in the striatum. In the histological examination, TH-positive cells with axons were observed at 2 and 4 weeks after the transplantation. As the dopamine transporter exists only in the axon terminal of DA neurons, these results suggested that PET measurements of [11C]PE2I binding indicated not only survival, but maturity and functioning of the transplanted cells. Repeated PET measurements of DA transporters are a useful tool in assessing the effectiveness of neural transplantations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16405076     DOI: 10.3727/000000005783982684

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

1.  Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Authors:  Jose A Rodríguez-Gómez; Jian-Qiang Lu; Iván Velasco; Seth Rivera; Sami S Zoghbi; Jeih-San Liow; John L Musachio; Frederick T Chin; Hiroshi Toyama; Jurgen Seidel; Michael V Green; Panayotis K Thanos; Masanori Ichise; Victor W Pike; Robert B Innis; Ron D G McKay
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

2.  Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model.

Authors:  Kuan-Yin Tseng; Jui-Sheng Wu; Yuan-Hao Chen; Mikko Airavaara; Cheng-Yi Cheng; Kuo-Hsing Ma
Journal:  Biomedicines       Date:  2022-06-19

Review 3.  PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Authors:  Patrick Emond; Denis Guilloteau; Sylvie Chalon
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.

Authors:  Cindy Casteels; Erwin Lauwers; Guy Bormans; Veerle Baekelandt; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

5.  Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats.

Authors:  Kiyoshi Kyono; Tadayuki Takashima; Yumiko Katayama; Toshiyuki Kawasaki; Riyo Zochi; Maki Gouda; Yasuhiro Kuwahara; Kazuhiro Takahashi; Yasuhiro Wada; Hirotaka Onoe; Yasuyoshi Watanabe
Journal:  EJNMMI Res       Date:  2011-11-10       Impact factor: 3.138

Review 6.  Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects.

Authors:  Annunziata D'Elia; Sara Schiavi; Andrea Soluri; Roberto Massari; Alessandro Soluri; Viviana Trezza
Journal:  Front Behav Neurosci       Date:  2020-12-11       Impact factor: 3.558

7.  The Effect of Sertoli Cells on Xenotransplantation and Allotransplantation of Ventral Mesencephalic Tissue in a Rat Model of Parkinson's Disease.

Authors:  Yun-Ting Jhao; Chuang-Hsin Chiu; Chien-Fu F Chen; Ta-Kai Chou; Yi-Wen Lin; Yu-Ten Ju; Shinn-Chih Wu; Ruoh-Fang Yan; Chyng-Yann Shiue; Sheau-Huei Chueh; Christer Halldin; Cheng-Yi Cheng; Kuo-Hsing Ma
Journal:  Cells       Date:  2019-11-11       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.